Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 10—October 2003
Research

Cephamycin Resistance in Clinical Isolates and Laboratory-derived Strains of Escherichia coli, Nova Scotia, Canada

Brian Clarke*, Margot Hiltz*, Heather Musgrave*, and Kevin R. Forward*Comments to Author 
Author affiliations: *Dalhousie University and the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

Main Article

Figure 2

Sequences of Escherichia coli AmpC attenuators that were other than the consensus sequence for E. coli K12. The hairpin loop is in boldfaced, and the region of the dyad symmetry is underlined. * indicates bp deletion. The number of strains with these mutations is indicated on the left.

Figure 2. Sequences of Escherichia coli AmpC attenuators that were other than the consensus sequence for E. coli K12. The hairpin loop is in boldfaced, and the region of the dyad symmetry is underlined. * indicates bp deletion. The number of strains with these mutations is indicated on the left.

Main Article

Page created: January 10, 2011
Page updated: January 10, 2011
Page reviewed: January 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external